Martina Maibach
Project Manager (Substitute for Christina Sina)

Maibach

Martina Maibach is part of the Wyss Zurich CeNeReg team since February 2018. After receiving her MSc in Cell Biology from ETH Zurich, she is currently pursuing a doctorate title in neuroscience. With her work, she aims to enhance axonal regeneration and functional recovery after injury to the central nervous system such as stroke or spinal cord injury. Martina joined the CeNeReg team as a temporal substitute for Christina Sina and will take over her responsibilities coordinating study drug production, logistics, and supply.

Contact:
martina.maibach@wysszurich.ch


Christina Sina
Co-Project Leader

Sina

Christina Sina joined the Wyss Zurich CeNeReg team in January 2016 and became Co-Project Leader in January 2018. She is responsible for coordinating study drug production, logistics, and supply. In addition, she is the scientific coordinator of Martin Schwab and supports the translation of his basic Nogo-A research into clinical application of the anti-Nogo-A antibody therapy. Christina holds a PhD in Immunology from the University of Zurich and worked in a PR agency for life science and health care communication.

Contact:
christina.sina@wysszurich.ch


Eduardo Vianna
Co-Project Leader

Vianna

Eduardo Vianna joined the Wyss Zurich CeNeReg team in January 2018 as Co-Project Leader. He is the CEO of the biotech startup company NovaGo Therapeutics AG and leads all clinical and business development activities related to the Nogo-A therapy. He holds a PhD in Neuroscience as well as an MBA and has more than 15 years of experience in neuroscience research and development. Prior to his current assignments, Eduardo Vianna worked for both Merck Serono and Roche, serving in global roles of increasing responsibility within medical affairs, clinical development, and portfolio management.

Contact:
eduardo.vianna@wysszurich.ch


Michael Maurer
Senior Scientist

Maurer

Michael Maurer is part of the Wyss Zurich CeNeReg team since January 2016. Originally coming from the pharmaceutical industry and being educated as chemical laboratory technician, he later received his MSc in Biotechnology from ETH Zurich and his PhD in Immunology from the University of Zurich. As Senior Scientist in the Schwab laboratory, his research focuses on Nogo-A antigens and anti-Nogo-A antibodies. Within the Wyss Zurich CeNeReg project, he serves as consultant for all antibody-related tasks and questions.

Contact:
michael.maurer@wysszurich.ch